BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21471644)

  • 1. Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys.
    Heo JH; Lee SR; Lee ST; Lee KM; Oh JH; Jang DP; Chang KT; Cho ZH
    J Alzheimers Dis; 2011; 25(3):517-23. PubMed ID: 21471644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin.
    Lee Y; Kim YH; Park SJ; Huh JW; Kim SH; Kim SU; Kim JS; Jeong KJ; Lee KM; Hong Y; Lee SR; Chang KT
    J Alzheimers Dis; 2014; 38(2):251-67. PubMed ID: 23948941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.
    Yeo HG; Lee Y; Jeon CY; Jeong KJ; Jin YB; Kang P; Kim SU; Kim JS; Huh JW; Kim YH; Sim BW; Song BS; Park YH; Hong Y; Lee SR; Chang KT
    J Alzheimers Dis; 2015; 46(4):989-1005. PubMed ID: 25881906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer's Rat Model.
    Chen Y; Guo Z; Mao YF; Zheng T; Zhang B
    Neurotox Res; 2018 May; 33(4):716-724. PubMed ID: 28929339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer's Disease Rat Model: A Proof-of-Concept Study.
    de Paula Faria D; Estessi de Souza L; Duran FLS; Buchpiguel CA; Britto LR; Crippa JAS; Filho GB; Real CC
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous nonmonotonic changes in functional connectivity and white matter integrity in a rat model of sporadic Alzheimer's disease.
    Tristão Pereira C; Diao Y; Yin T; da Silva AR; Lanz B; Pierzchala K; Poitry-Yamate C; Jelescu IO
    Neuroimage; 2021 Jan; 225():117498. PubMed ID: 33164858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism.
    Grieb P
    Mol Neurobiol; 2016 Apr; 53(3):1741-1752. PubMed ID: 25744568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease.
    Labak M; Foniok T; Kirk D; Rushforth D; Tomanek B; Jasiński A; Grieb P
    Acta Neurochir Suppl; 2010; 106():177-81. PubMed ID: 19812944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE.
    Jupp B; Williams J; Binns D; Hicks RJ; Cardamone L; Jones N; Rees S; O'Brien TJ
    Epilepsia; 2012 Jul; 53(7):1233-44. PubMed ID: 22686573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptozotocin-induced sporadic Alzheimer's disease: selection of appropriate dose.
    Mehla J; Pahuja M; Gupta YK
    J Alzheimers Dis; 2013; 33(1):17-21. PubMed ID: 22886014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
    Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
    Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
    Tahirovic I; Sofic E; Sapcanin A; Gavrankapetanovic I; Bach-Rojecky L; Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P
    J Neural Transm Suppl; 2007; (72):235-40. PubMed ID: 17982899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
    Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
    Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of appropriate reference genes for RT-qPCR analysis in a streptozotocin-induced Alzheimer's disease model of cynomolgus monkeys (Macaca fascicularis).
    Park SJ; Kim YH; Lee Y; Kim KM; Kim HS; Lee SR; Kim SU; Kim SH; Kim JS; Jeong KJ; Lee KM; Huh JW; Chang KT
    PLoS One; 2013; 8(2):e56034. PubMed ID: 23457495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cholinergic function and metabolic changes in streptozotocin-induced rat brain injury.
    Yuliani T; Lobentanzer S; Klein J
    J Neurochem; 2021 Sep; 158(6):1307-1319. PubMed ID: 33448390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin.
    Kraska A; Santin MD; Dorieux O; Joseph-Mathurin N; Bourrin E; Petit F; Jan C; Chaigneau M; Hantraye P; Lestage P; Dhenain M
    PLoS One; 2012; 7(9):e46196. PubMed ID: 23049978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
    Du LL; Chai DM; Zhao LN; Li XH; Zhang FC; Zhang HB; Liu LB; Wu K; Liu R; Wang JZ; Zhou XW
    J Alzheimers Dis; 2015; 43(3):775-84. PubMed ID: 25114075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.